HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anthony Delalande Selected Research

Ytterbium

10/2021Doxorubicin-Sensitized Luminescence of NIR-Emitting Ytterbium Liposomes: Towards Direct Monitoring of Drug Release.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anthony Delalande Research Topics

Disease

1Neoplasms (Cancer)
10/2021
1Hypoxia (Hypoxemia)
01/2021
1Wounds and Injuries (Trauma)
10/2015
1Intraoperative Complications
10/2015
1Cholera
07/2015
1Adenocarcinoma
02/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2014

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
10/2021 - 02/2014
1liposomal doxorubicin (Doxil)FDA Link
10/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2021
1YtterbiumIBA
10/2021
1inositol trispyrophosphateIBA
01/2021
1PolymersIBA
10/2015
1FibromodulinIBA
10/2015
1Liposomes (Liposome)IBA
10/2015
1LipidsIBA
07/2015
1LuciferasesIBA
02/2014
1NucleosidesIBA
02/2014
1GemcitabineFDA Link
02/2014

Therapy/Procedure

1Therapeutics
02/2014
1Drug Therapy (Chemotherapy)
02/2014